Dr. Schwen on focal therapies for prostate cancer
Zeyad Schwen, MD, a urologic oncologist at Cleveland Clinic, discusses how patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment for prostate cancer.
A new standard emerges in advanced urothelial carcinoma after decades of first-line chemotherapy
Data from the EV-302 trial showed a doubling of progression-free survival and overall survival with the ADC/checkpoint combination versus standard chemotherapy.
Cleveland Clinic trial compares shockwave vs radial wave therapy for ED in prostate cancer survivors
Novel research to evaluate noninvasive treatments in erectile dysfunction and chronic pelvic pain
Germline biomarker offers insight into treatment selection for men with prostate cancer
Correlation found between the biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy
Cleveland Clinic urologist to lead esteemed medical journal
Hadley Wood, MD, shares her vision as the new editor-in-chief of Urology.
Dr. Mian on emerging molecular biomarkers for genitourinary cancers
On an episode of Cleveland Clinic’s Cancer Advances podcast, host Dale Shepard, MD, PhD, talks with Omar Mian, MD, PhD, about emerging molecular biomarkers for genitourinary cancers.
Novel approach shows efficacy in fragmenting kidney stones
Cleveland Clinic is the first to investigate photonic nanoparticles as a potential kidney stone treatment.
Optimizing outcomes in sacral neuromodulation for overactive bladder
These findings may help guide decision-making in the initial testing phase of the [sacral neuromodulation] device prior to permanent implant or explant, according to Bradley Gill, MD, of the Cleveland Clinic.
Study suggests broader use of anastrozole for male infertility
If replicated with further study, the finding potentially expands noninvasive fertility treatment options and may minimize the need for expensive reproductive technology, according to lead author Scott D. Lundy, MD, PhD, of Cleveland Clinic’s Department of Urology.
Cleveland Clinic survey examines the current state of men’s health in America
National MENtion It® campaign explores the impact stress has on men’s sexual and mental well-being.
Targeted neoadjuvant therapy for high-complexity cases of renal masses in a solitary kidney
A Cleveland Clinic study found that TKIs in the neoadjuvant setting are associated with greater use of partial nephrectomy when treating patients diagnosed with renal masses in a solitary kidney.
Cleveland Clinic–led study shows potential benefits of ultrasound-guided prostate SBRT
The published findings show the viability of using a transperineal ultrasound system as a means to monitor intra-fractional prostate motion for prostate stereotactic body radiotherapy.
Cleveland Clinic shares its institutional experience with aquablation for BPH
Aquablation is a “minimally invasive procedure [that] is safe with long-term durability and a low-side effect profile,” said urologist Dennis Bentley, MD.
Moving closer toward narcotic-free kidney transplantation
Smaller incision may lead to reduced postoperative pain for some patients.
Race-modified equations contribute to disparity in partial nephrectomy use in black patients
“Our findings show that race-modified equations account for some but not all of the disparity in partial nephrectomy use. We need to keep searching for answers to ensure people of all races receive appropriate care," said Christopher Weight, MD.
The complex bacterial colonization of penile implants
“This study truly changes the paradigm of infections and suggests we need to work smarter, not harder, to prevent infections,” said urologist Scott Lundy, MD, PhD.
First-in-Human study shows safety, feasibility of UroMonitor
UroMonitor was developed in response to conventional urodynamics, which have several limitations.
Testosterone-Replacement therapy does not increase incidence of major adverse cardiac events for men with hypogonadism
Researchers still urge caution when considering testosterone therapy.
Yes, vasectomies may actually have risen since SCOTUS ruling
Study finds a 35% increase in vasectomy consultation requests.
Rethinking creatinine to estimate kidney function in non–weight-bearing individuals
The findings suggest creatinine-based eGFR equations alone may be inaccurate, and cystatin C or combined eGFR equations may be a more accurate assessment of kidney function in this population.
Harvesting a rectal mucosa graft using the single-port robotic system for a substitution urethroplasty
Cleveland Clinic surgeons describe a new technique for harvesting a rectal mucosa graft.
Dr. Weight on how robotic-assisted surgery is improving recovery time in patients with metastatic testicular cancer
In an episode of Cleveland Clinic’s Cancer Advances podcast, Christopher Weight, MD, center director of Urologic Oncology at Cleveland Clinic, discusses robot-assisted retroperitoneal lymph node dissection.
Cleveland Clinic performs its first HIV-positive to HIV-positive kidney transplant case
“The need for lifesaving organs continues to grow. We continue to increase patients’ options regarding the type of donors. We want them to get this life-changing procedure as soon as possible,” said Alvin Wee, MD.
Minimally invasive focal therapy promising approach for select patients with prostate cancer
Cleveland Clinic highlights its use of irreversible electroporation, also known as Nanoknife, in select patients with prostate cancer.
From staging to surgery: How innovation is customizing urologic care
Innovation is at the cornerstone for care in Cleveland Clinic’s Department of Urology, and it’s enabling experts to deliver more personalized approaches to patients.
Cleveland Clinic urologists show how machine learning could revolutionize overactive bladder care
Machine learning isn’t new to medicine or to urology, but its potential remains largely untapped, according to the authors of two new Cleveland Clinic–led studies.
Robotic prostatectomy without ventilator general anesthesia? SP transvesical prostatectomy is making it a reality
Patients can now undergo prostate surgery with epidural anesthesia and light sedation, known as twilight sleep, without the need for a ventilator general anesthesia.
Testicular tissue cryopreservation offers hope to prepubescent males at risk for infertility
A team of Cleveland Clinic urologists and pediatric oncologists has developed a streamlined testicular tissue collection and storage process. They have enrolled and cryopreserved testicular tissue for nearly a dozen young patients so far.
New guideline on neurogenic lower urinary tract dysfunction emphasizes risk management
Cleveland Clinic specialist discusses the implications of the first published guideline for neurogenic lower urinary tract dysfunction
Rare case of Skene’s gland malignancy raises awareness about treatment options
ADT and other mainstays of therapy for men with castration-resistant prostate cancer may be effective in the management of Skene’s gland malignancy, a rare paraurethral adenocarcinoma.
2 Clarke Drive Cranbury, NJ 08512